Coronary Microvascular Dysfunction in Ischaemic Heart Disease: Lessons From Large Animal Models
Basic & Clinical Pharmacology & Toxicology · 2025-08 · 137 (2)
DOI: 10.1111/bcpt.70074 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 09.07.2025. Verfasst von Oana Sorop und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherla…. Hauptthemen laut MEDLINE: Myocardial Ischemia, Coronary Circulation, Microcirculation, Coronary Vessels. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Dutch Cardiovascular Alliance, German Center for Cardiovascular Research.
Abstract (Originalsprache)
The coronary microvasculature is principally responsible for matching coronary blood flow to myocardial demand of oxygen and nutrients. Short‐term control of coronary blood flow is achieved via alterations in coronary microvascular tone, whereas long‐term control of coronary flow also involves remodelling of the coronary microvasculature, including adjustments in vascular structure, diameter and density. In the past 50 years, considerable research efforts have been directed at understanding the functional and structural coronary microvascular adaptations involved in matching myocardial oxygen supply to demand, and how these mechanisms are affected by various diseases. In this review article, we will discuss our current understanding of the mechanisms underlying the regulation of coronary microvascular tone under healthy physiological conditions and in ischaemic heart disease. We will specifically discuss the role of microvascular dysfunction in obstructive and non‐obstructive coronary artery disease, as studied in large animal models and confirmed in human studies. Future research should be directed at further unravelling the disease‐specific mechanisms of coronary microvascular dysfunction in order to identify therapeutic targets to improve microvascular function in patients with ischaemic heart disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
- Institute for Surgical Research, Walter Brendel Center of Experimental Medicine (WBex), University Clinic Munich, Munich, Germany.
- German Center for Cardiovascular Research (DZHK), Munich Heart Alliance (MHA), Partner Site Munich, Munich, Germany.
ORCID-Profile: Oana Sorop
Förderung
- Dutch Cardiovascular Alliance
- German Center for Cardiovascular Research
Zitieren
APA
Sorop, O., van de Wouw, J., Merkus, D., & Duncker, D. J. (2025). Coronary Microvascular Dysfunction in Ischaemic Heart Disease: Lessons From Large Animal Models. Basic & Clinical Pharmacology & Toxicology, 137(2). https://doi.org/10.1111/bcpt.70074
Vancouver
Sorop O, van de Wouw J, Merkus D, Duncker DJ. Coronary Microvascular Dysfunction in Ischaemic Heart Disease: Lessons From Large Animal Models. Basic & Clinical Pharmacology & Toxicology. 2025;137(2). doi:10.1111/bcpt.70074
BibTeX
@article{Sorop2025,
author = {Sorop, Oana and van de Wouw, J and Merkus, Daphne and Duncker, Dirk J},
title = {Coronary Microvascular Dysfunction in Ischaemic Heart Disease: Lessons From Large Animal Models},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
volume = {137},
number = {2},
doi = {10.1111/bcpt.70074}
}
EUVIMED